Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.
Publication
, Journal Article
Cohen, HJ; Silberman, HR; Larsen, WE; Johnson, L; Bartolucci, AA; Durant, JR
Published in: Blood
October 1979
Duke Scholars
Published In
Blood
ISSN
0006-4971
Publication Date
October 1979
Volume
54
Issue
4
Start / End Page
824 / 836
Location
United States
Related Subject Headings
- Risk
- Prednisone
- Nitrosourea Compounds
- Neoplasm Staging
- Multiple Myeloma
- Immunology
- Humans
- Drug Therapy, Combination
- Cyclophosphamide
- Carmustine
Citation
APA
Chicago
ICMJE
MLA
NLM
Cohen, H. J., Silberman, H. R., Larsen, W. E., Johnson, L., Bartolucci, A. A., & Durant, J. R. (1979). Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma. Blood, 54(4), 824–836.
Cohen, H. J., H. R. Silberman, W. E. Larsen, L. Johnson, A. A. Bartolucci, and J. R. Durant. “Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.” Blood 54, no. 4 (October 1979): 824–36.
Cohen HJ, Silberman HR, Larsen WE, Johnson L, Bartolucci AA, Durant JR. Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma. Blood. 1979 Oct;54(4):824–36.
Cohen, H. J., et al. “Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.” Blood, vol. 54, no. 4, Oct. 1979, pp. 824–36.
Cohen HJ, Silberman HR, Larsen WE, Johnson L, Bartolucci AA, Durant JR. Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma. Blood. 1979 Oct;54(4):824–836.
Published In
Blood
ISSN
0006-4971
Publication Date
October 1979
Volume
54
Issue
4
Start / End Page
824 / 836
Location
United States
Related Subject Headings
- Risk
- Prednisone
- Nitrosourea Compounds
- Neoplasm Staging
- Multiple Myeloma
- Immunology
- Humans
- Drug Therapy, Combination
- Cyclophosphamide
- Carmustine